1
Home
Companies

Anteris Technologies

Anteris Technologies
Leadership team

Mr. Wayne G. Paterson (CEO, MD & Exec. Director)

Mr. Matthew McDonnell (Chief Financial Officer)

Mr. David St. Denis (Chief Operating Officer)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Toowong, Queensland, Australia
Established
1999
Revenue
2M - 5M
Traded as
ASX:AVR
Social Media
URL
https://www.anteristech.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
History

Anteris Technologies was founded in 2016 by healthcare innovator Dr. Mark Stenz. Since then, the company has grown from a small team of three to a team of over 100. Anteris has released a number of proprietary solutions for healthcare providers, including a mobile app for patient records, a cloud-based billing system, and a web-based platform for communication between providers and their patients.

Mission
At Anteris Technologies, our mission is to improve patient access and engagement in healthcare services by developing innovative technologies that streamline processes and facilitate communication between patients and providers.
Vision
Our vision is to be the leader in healthcare technology solutions, empowering providers to deliver high-quality care, and providing patients with the tools they need to participate actively in their health and well-being.
Key Team

Mr. Stephen Denaro (Independent Non-Exec. Director & Company Sec.)

Mr. Chris Olig (Bus. Devel. and Portfolio Planning Director)

Dr. Chris Meduri M.D., M.P.H. (Chief Medical Officer & Member of Medical Advisory Board)

Mr. Danny Zanardo (Commercial Director of International)

Prof. Ian Hector Frazer AC, FAA, FRS, M.D. (Exec.)

Recognition and Awards
Anteris Technologies has been recognized as one of the fastest-growing companies in the healthcare industry by Inc. Magazine, Forbes, and Deloitte, and has been featured in numerous publications, including the Wall Street Journal, TechCrunch, and CNBC.
References

https://in.investing.com/equities/admedus-fpo

https://finance.yahoo.com/quote/AVR.AX/profile?p=AVR.AX

https://www.crunchbase.com/organization/allied-healthcare-group

https://www.anteristech.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Anteris Technologies
Leadership team

Mr. Wayne G. Paterson (CEO, MD & Exec. Director)

Mr. Matthew McDonnell (Chief Financial Officer)

Mr. David St. Denis (Chief Operating Officer)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
0 - 50
Headquarters
Toowong, Queensland, Australia
Established
1999
Revenue
2M - 5M
Traded as
ASX:AVR
Social Media
URL
https://www.anteristech.com